Correlation Between Givaudan and Novozymes

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Givaudan and Novozymes at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Givaudan and Novozymes into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Givaudan SA and Novozymes AS, you can compare the effects of market volatilities on Givaudan and Novozymes and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Givaudan with a short position of Novozymes. Check out your portfolio center. Please also check ongoing floating volatility patterns of Givaudan and Novozymes.

Diversification Opportunities for Givaudan and Novozymes

GivaudanNovozymesDiversified AwayGivaudanNovozymesDiversified Away100%
0.07
  Correlation Coefficient

Significant diversification

The 3 months correlation between Givaudan and Novozymes is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Givaudan SA and Novozymes AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novozymes AS and Givaudan is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Givaudan SA are associated (or correlated) with Novozymes. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novozymes AS has no effect on the direction of Givaudan i.e., Givaudan and Novozymes go up and down completely randomly.

Pair Corralation between Givaudan and Novozymes

Assuming the 90 days horizon Givaudan is expected to generate 17.5 times less return on investment than Novozymes. In addition to that, Givaudan is 1.17 times more volatile than Novozymes AS. It trades about 0.0 of its total potential returns per unit of risk. Novozymes AS is currently generating about 0.08 per unit of volatility. If you would invest  5,641  in Novozymes AS on December 6, 2024 and sell it today you would earn a total of  203.00  from holding Novozymes AS or generate 3.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Givaudan SA  vs.  Novozymes AS

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -50510
JavaScript chart by amCharts 3.21.15GVDBF NVZMY
       Timeline  
Givaudan SA 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Givaudan SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental drivers, Givaudan is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar4,1004,2004,3004,4004,5004,600
Novozymes AS 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Over the last 90 days Novozymes AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, Novozymes is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar5556575859606162

Givaudan and Novozymes Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-8.35-6.25-4.16-2.060.03522.084.196.38.41 0.050.100.150.20
JavaScript chart by amCharts 3.21.15GVDBF NVZMY
       Returns  

Pair Trading with Givaudan and Novozymes

The main advantage of trading using opposite Givaudan and Novozymes positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Givaudan position performs unexpectedly, Novozymes can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novozymes will offset losses from the drop in Novozymes' long position.
The idea behind Givaudan SA and Novozymes AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Commodity Directory
Find actively traded commodities issued by global exchanges
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format